Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...
Dr. Kaustubh Mahamine, Dr. Ruchir Rastogi, Dr. B. Srihari, and Dr. Chandra Prakash Thakur — will share expert perspectives on the evolving management of Coronary Artery Disease in diabetic patients.
New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have ...
A. Diabetes is a chronic illness that develops from a combination of genetics, diet and lifestyle. Too much sugar in the ...
Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...
The analysis examined GLP-1 drug use following 382,277 pregnancies in Denmark from the beginning of 2018 through June 2024.
Background Non-adherence to antidiabetic medication remains a major barrier to achieve optimal health outcomes among individuals with diabetes, particularly in developing countries. This issue ...
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...
Diabetes is hitting younger Fijians harder, threatening families and the workforce. Assistant Minister for Health Penioni ...
Poles have been encouraged to undergo regular medical tests and follow dietary guidelines ahead of World Diabetes Day on ...
With sustained lifestyle changes, some people with diabetes can keep their blood sugar levels in the normal range without medication. While not a permanent cure, remission highlights how proactive hab ...
A major new study from Mass General Brigham uncovers how two leading diabetes medications, tirzepatide and semaglutide, stack up in protecting the heart. Using real-world data from nearly a million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results